September 5, 2017: Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial
Protembis announced today the first clinical applications of its ProtEmbo® Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo® System is an intra-aortic filter device that deflects embolic material arising during TAVR away from the brain.
July 28, 2015: Medical device company Protembis GmbH has closed its seed financing round
Led by Innovationsstarter Fonds Hamburg GmbH, Geratherm Medical AG and a group of angel investors, the financing will fund R&D and clinical trials of its novel cerebral protection device.
Come and meet Protembis at PCR Innovators Day London 2017
Click image for program
April 24. 2015: Protembis wins state subsidy programme
Protembis wins state subsidy programme “KMU-innovativ” for innovative small and medium-sized enterprises granted by Germany's Federal Ministry of Education and Research.
July 25, 2017: Protembis initiates collaboration with German Accelerator Life Sciences
Protembis initiates the collaboration with the German Accelerator Life Sciences (GALS) program, an initiative supported by the German Federal Ministry for Economic Affairs and Energy (BMWi), to facilitate its U.S. expansion and accelerate its clinical development plans.